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HOW HUMAN GENETICS CAME TO SA
Phase one: The early laboratory
Historically, the first laboratory discipline that most human genetics 
departments introduce has been a cytogenetic laboratory. Although 
this technically did happen in Cape Town at the University of Cape 
Town (UCT), there was a slight variation in the timing of this 
procedure as the laboratory preceded the department. In 1970, a 
small cytogenetics laboratory was opened in the Department of 
Physiology, under the auspices of Dr Pauline Webb, when Prof. A W 
Sloan was the head of department (HOD). In January 1971, Jacquie 
Greenberg (JG), a recent graduate from Stellenbosch University, was 
appointed as a temporary lecturer for 6 months as a locum for Pauline 
Webb who went on sabbatical leave. JG took over the oversight of the 
laboratory where Penny Kemp, a technologist from England, did the 
tissue culturing and karyotyping. JG, a full Professor at UCT from 
2009, remained in the Faculty of Health Sciences (FHS) at UCT until 
her retirement in 2015. In August 1971, Ronald Smart (RS) from 
the University of Edinburgh was employed to formally activate the 
diagnostic laboratory with a view to offering a laboratory service to 
the local hospitals in the Western Cape.
In those early days, the laboratory was housed in one room in 
the basement of the physiology building (officially known as 
Wernher & Beit South from 1925)[1] and outside the window, which 
was often open, lived a large number of the genus Xenopus (African 
clawed frog) used for pregnancy testing – a technique developed by 
H Zwarenstein at UCT in 1934.[2] This one room was used for setting up 
blood cultures, harvesting the cells to produce chromosomes, microscopic 
analysis and karyotyping. There were also a number of dassies caged 
nearby, and on one occasion a dassie made its escape into the dark room 
where photographs were developed for karyotyping. Needless to say, 
contamination was an ongoing problem! Those were interesting times.
In April 1972, Peter Beighton (PB) was appointed as the first 
Professor of Human Genetics at UCT[3] and the cytogenetics unit was 
incorporated into this new department, and housed in the then New 
Anatomy Building. The new laboratory had sealed sterile rooms, a 
dark room as well as a microscope and karyotyping area. At this stage 
the staff complement increased and routine chromosome analysis on 
blood samples was introduced. Later in 1972, Dr Molly Nelson (MN), 
a paediatrician with a special interest in clinical genetics, also from 
the University of Edinburgh, joined the department and was involved 
in the running of the cytogenetic section. At this point the laboratory 
was able to cope with the blood samples being sent for chromosome 
analysis and it was possible for RS to accompany MN on a regular 
basis to the various neonatal and paediatric wards. In this way a first-
hand comprehensive knowledge of dysmorphology was obtained by 
the laboratory staff.
In those early days, the laboratory introduced culture and 
analysis of amniotic fluid samples. It is difficult to imagine that 
in the first year only 20 such samples were received. It is also of 
historical note that many samples were taken at that time without 
the use of ultrasound guidance. As a result, about one-third of 
the samples were contaminated with blood. A large number of 
these failed to grow successfully but with the introduction of 
ultrasound, the number of clear samples increased to almost 100%, 
and the culture success rate rose accordingly. When the screening 
of chromosomes obtained from amniotic fluid was first started, a 
method using quinacrine stain was used – a fluorescent staining 
method that could identify the Y chromosome. The routine Giemsa 
staining at this stage was prior to G banding and it was useful, and 
at times reassuring, to know whether the fetus was male or female. 
As this was a quick and simple test, the method was used routinely 
for many years. In addition, a service for cytogenetic analysis of skin 
and other tissue types was introduced. These were normally sent to 
confirm a previous blood diagnosis, or those from fetal tissue where 
a chromosome abnormality was suspected.
It was in this era that Prof. Peter Jacobs, the then Head of 
Haematology, approached the department to have a cytogenetic 
service available for some of his patients. The laboratory was able 
to begin this service immediately, mainly to detect the deletion in 
chromosome 22, known as the Philadelphia chromosome, often 
found in cases of chronic myeloid leukaemia. In addition, bone 
marrow (BM) cultures from patients who had undergone BM 
transplants were also established for further analysis. The idea 
was to look for markers in the chromosomes that would confirm 
that the transplant had been successful. If the donor was of a 
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different sex to the recipient then it was a simple way to confirm 
the donor chromosomes. However, in same-sex donor/recipient 
patients, detection of small markers specific to the donor marrow 
chromosomes had to be established and relied upon.
It was decided at this stage to undertake a cytogenetic survey 
of the patients housed in the Alexandra Care and Rehabilitation 
Centre (formerly known as the Alexandra Institution). Accordingly, 
personnel from the laboratory visited the hospital each week and 
drew blood from five patients. Those samples were cultured and 
analysed and the results published some years later in 1982.[4] Apart 
from the expected number of Down syndrome patients confirmed 
by chromosome studies, there were not a great many chromosome 
abnormalities in this population. However, it was noted that 
culturing of these bloods was problematic in that the number of 
metaphases obtained was low and the quality of the chromosomes 
was very poor indeed. This anomaly was present throughout the 
trial and in spite of attempts to improve the mitotic index, the 
situation was not remedied. It was not possible to explain why these 
cultures were so poor, compared with the samples set up at the same 
time under identical conditions from patients from other centres 
or hospitals. 
Phase two: Expansion
In 1973, a biochemistry laboratory was opened in the same building, 
initially set up and run by JG. She was subsequently joined by Dr 
Howard Henderson, who transferred to the department from Red 
Cross War Memorial Children’s Hospital (RCWMCH) chemical 
pathology laboratory in 1974. 
In 1976, two individuals in South Africa (SA) were registered as 
Genetic Counsellors with the South African Medical and Dental 
Council. One was RS, working in the UCT laboratory and the other 
was Dr Stander Jansen, then head of the cytogenetic laboratory at 
University of the Free State. This opened up a novel combination for 
laboratory staff members to be involved in clinical service and was 
of great value when discussing laboratory findings directly with the 
patient. In this regard, and that of the earlier instances concerning 
the ward visits and subsequent teaching in dysmorphology, the UCT 
Department of Human Genetics was unique in the opportunity in 
which the laboratory staff found themselves. Prof. Beighton also 
organised weekly seminars that were open to all medical school staff. 
In addition, the department held weekly clinical meetings where 
staff from the laboratories, which now included the biochemistry 
section, and the clinical staff discussed cases, problems and future 
developments. As Prof. Beighton had a special interest in bone 
disorders, many of the presentations included an array of X-rays and 
all the staff members became well versed in viewing and commenting 
on the radiological abnormalities and anomalies to which they were 
exposed. In one case, a mosaic trisomy 8 was noted in a patient with 
broad clavicles.[5] It cannot be stressed enough how important this 
clinical input, which PB encouraged in all its various forms, was to 
the laboratory staff and we were, and still are, grateful that the HOD 
placed so much weight on the clinical aspect of genetics.
In 1984, a molecular laboratory was opened next to the 
biochemistry laboratory, under the leadership of Dr Gillian Wallis. 
She was subsequently joined by JG, who then registered as a PhD 
student under GW and PB’s supervision in 1987. The cytogenetic 
laboratory moved into a newly furbished adjoining laboratory and 
there can be no doubt that having the three laboratory disciplines 
housed together was a major advantage and the constant and regular 
contact with the clinical team was of great benefit to all concerned. 
The cytogenetic laboratory staff continued to grow and samples were 
sent for culture and analysis from as far away as the Eastern Cape 
and Namibia. In 1987, Dr Nelson retired and the laboratory was then 
run by RS.
During the 1980s, the laboratory purchased a semi-automated 
karyotyping system that allowed the chromosomes to be identified 
on a computer screen. Photographs were obtained digitally, 
directly from the microscopes, thereby alleviating the need for a 
dark room. The chromosome abnormality rate in blood samples 
remained constant at about 20% per annum and the amniotic 
fluid abnormalities detected ranged between 7% and 12%. This 
was considerably more than some overseas centres and reflects 
the strict criteria imposed by the laboratory on patients being 
referred for chromosome analysis. In 1969, Lubs[6] described a 
condition of mental retardation among male members in one 
family. This so-called ‘fragile X syndrome’, which could only be 
detected using a modified culture technique, was later described 
by Sutherland.[7] Laboratories worldwide re-examined earlier cases, 
usually when two or more male siblings were mentally retarded 
and had other physical signs of this newly discovered condition, 
but where previous chromosome studies on these individuals had 
been reported as normal. The UCT laboratory also recalled such 
patients, as did the other laboratories in SA. One large family[8] and 
a small number of other families were identified. It was thought 
that this condition could be as common as Down syndrome, if 
not more prevalent. However, after the initial surge in referrals, 
it became apparent that this was not the case and these findings 
were subsequently reported.[9] Contact with the other SA centres 
confirmed this observation. It then became possible to identify 
positive cases using molecular genetic techniques. However, the 
number of positive cases using this method remained low. When 
a positive case was identified, cytogenetic studies were also carried 
out and it was gratifying to note that the two methods always 
confirmed each other.
Around this time, many centres overseas had introduced 
chromosome analyses on chorion villi samples. The UCT laboratory 
did some work in this field and RS was afforded the opportunity 
to learn the technique at British Columbia Children’s Hospital in 
Vancouver. Many of the potential referrals would have come from 
the advanced maternal age group, but many of those patients believed 
that they ‘knew the ropes’ and so did not present themselves early 
enough in pregnancy (ideally at 10 - 11 weeks) for the test to be 
offered.
During the 1990s, there was considerable financial restraint 
placed on the health services in SA, which also impinged on the 
laboratories. In particular, if a staff member resigned, the post was 
not filled. Eventually some restrictions had to be enforced on the 
referral criteria. As amniotic fluid results are required urgently, the 
only way to report on those within an acceptable timeframe was to 
limit the intake from patients of advanced maternal age. The criteria 
were changed to a maternal age of 40 years and over, instead of the 
previous age of 35 years and over.
Ironically, in contrast to this limitation on the antenatal chromo-
some studies, a new technique known as fluorescence in situ 
hybridisation (FISH) was being introduced in many cytogenetic 
laboratories internationally. Trials were introduced and the UCT 
laboratory also began offering this FISH service. FISH is a combination 
of cytogenetic and molecular methodologies, where both metaphase 
and interphase cells can be analysed using whole chromosome 
paints (DNA probes) for the identification of translocations, 
centromere-specific probes for aneuploidy, and locus-specific probes 
for deletions, duplications and detection of gene rearrangements 
found in oncology-related conditions. Fluorochrome markers allow 
visualisation of the abnormalities using a fluorescent microscope. 
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This technique provides a quick method for detecting the common 
trisomies – 21, 18 and 13 – without the need for culture. In addition 
to the use of FISH in antenatal diagnosis, the same method could be 
utilised for urgent confirmation of a clinical diagnosis in newborn 
babies, and this was also introduced on a routine basis. FISH studies 
in haematology disorders that had subtle chromosome abnormalities 
also increased dramatically. At this stage, the laboratory’s range of 
tests still did not include haematological cytogenetics (including 
the new FISH studies) and those continued to be undertaken by the 
Department of Haematology.
While all this expansion was occurring, the laboratory moved yet 
again in 2003 to the Falmouth Building, FHS. At this stage, another 
change of great importance occurred with the introduction of the 
new National Health Laboratory Service (NHLS) being introduced 
nationwide. This resulted in a strengthening of the laboratory 
diagnostic services in general and allowed the cytogenetic laboratory 
to employ new staff including student medical technologists. Also, 
as a result of this new takeover there was collaboration between the 
UCT laboratory and the laboratory at Tygerberg Hospital, with the 
administration of the latter being taken over by RS although the 
laboratories continued to work independently.
At the end of 2006, a new laboratory was allocated space at Groote 
Schuur Hospital (GSH) and RS was able to have some input into the 
design of the new laboratory, although never having the opportunity to 
work in it as he retired as head of the laboratory; the position of head 
was taken over by GS, who had been involved with the department 
for many years working in the biochemistry and molecular sections, 
as well as cytogenetics. Subsequently GS was appointed by the NHLS 
as the Discipline Specific Laboratory Manager for Cytogenetics, which 
was still housed in the Falmouth Building.
GS attended the 9th course in Molecular Cytogenetics and DNA 
Microarrays in October 2007 (EGF University Bertinoro, Italy) with a 
view to preparing the laboratory to have amniotic fluid samples ready 
for testing when the molecular laboratory had the necessary filters 
for quantitative fluorescence-polymerase chain reaction (QF-PCR) 
analysis.[10] Samples for haematology cytogenetics were sent from 
GSH and the private haematology units. All staff rotated through this 
area to become proficient in BM analysis.
Phase three: The present laboratory
In December 2007, the cytogenetics laboratory, consisting of five 
medical technologists and one student in cytogenetics, made the 
move from the FHS to the newly completed laboratory in GSH. 
This new NHLS section[11] at GSH, called C21, housed a molecular 
genetics laboratory for haematology, chemistry, genetics, tissue 
immunology and the new cytogenetics karyotyping laboratory, 
incorporating FISH for acquired and constitutional conditions. With 
RS’s retirement, the diagnostic laboratory, although academically 
connected with UCT, was then entirely run under the auspices of 
the NHLS and all cytogenetic staff members are now employed by 
the NHLS.
Once the move to the new laboratory had been completed, 
a number of major changes took place involving research and 
development of new techniques and significant changes to the staff 
complement. The haematology cytogeneticist who had been working 
in isolation in a haematology laboratory moved into the cytogenetics 
laboratory, bringing with her an additional station for the automatic 
karyotyping system, which had been installed in June 2007. The 
laboratory now had three karyotyping stations linked to a system 
that allowed capture of the chromosomes in metaphase, sorting on 
screen, with application of ideogram data and a print-out of the final 
karyotype with patient details. The inclusion of the BM haematology 
work into the laboratory enhanced the teaching requirements for 
medical technologists wanting to write the Medical Technology 
board exam for cytogenetics. Between December 2007 and May 2009, 
haematology FISH was established in the cytogenetics laboratory 
for haematological cancer identification and detection of minimal 
residual disease, in conjunction with polymerase chain reaction 
(PCR) technology done in the molecular genetics laboratory 
The administration system used by the NHLS was adopted for 
logging and reporting samples. The inter-laboratory sample exchange 
that had been instituted in 2007 was replaced with an external quality 
control programme from the College of American Pathologists. All 
technologists were given the opportunity to analyse the challenge 
samples including karyotyping, aneuploidy, microdeletion and 
oncology FISH analysis. Now that the cytogenetics laboratory had a 
permanent home, application was made for South African National 
Accreditation System (SANAS) accreditation. The first assessment 
by SANAS was done in the cytogenetics laboratory in 2008 and the 
laboratory passed with flying colours.[12]
Investigations were also being undertaken to introduce faster 
molecular techniques for antenatal diagnosis. FISH for aneuploidy 
was well established, and samples from GSH and Tygerberg Hospital 
were being processed. The next, possibly cheaper, option – a 
quantitative PCR method, QF-PCR – was considered in collaboration 
with UCT.
When GS left the laboratory at the end of May 2009, there 
were seven qualified cytogenetic medical technologists, one student 
medical technologist and the cost centre supported one scientist 
and two genetic counsellors. SANAS had completed two successful 
assessments of the laboratory with no non-conformances. Detection 
rate of abnormal cytogenetics was running constantly at 20%. GS was 
the academic advisor for the software development of the LabTrak 
Health Laboratory Information System. The managerial responsibility 
was handed over to Theresa Ruppelt (TR), an experienced senior 
technologist in the laboratory.
In 2009, TR was appointed to the post of Laboratory Manager. 
The first goal for the year was the consolidation of the Tygerberg 
Hospital (TBH) cytogenetics laboratory with the GSH laboratory. 
During September and October 2010, samples originating in TBH 
were sent to GSH, and the TBH cytogenetics laboratory closed 
in December 2010. These extra samples effectively doubled the 
workload. However, the turnaround time (TAT) remained the same. 
All FISH requests were already being done at GSH. Collaboration 
between the cytogenetic and molecular laboratories increased and 
cross-training of the cytogenetic technologists was accomplished. 
This was especially advantageous in light of the international 
trend towards molecular cytogenetic methods. One of the medical 
technologists in cytogenetics moved to the molecular laboratory on a 
permanent basis. All administrative duties were taken over from the 
technical staff by the appointment of a laboratory clerk in 2010. This 
assisted greatly in the improvement of the total TAT. There was an 
increase in requests for chromosome breakage studies for Fanconi’s 
anaemia investigation and this test was validated for implementation 
in 2010.
Following the release of the consensus statement by Miller 
et al.[13] recommending chromosomal microarray as the first-
tier test in the diagnosis of developmental delay and multiple 
congenital abnormalities, a translational project was proposed for 
the diagnostic use of chromosomal microarray. The karyotyping 
system had a software update and an additional review station 
was installed in 2011. The new software improved the resolution 
of the karyotyping images. A further consolidation of cytogenetic 
services occurred in 2011 with the referral of all BM FISH and BM 
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culture requests from RCWMCH to GSH towards the end of the 
year. QF-PCR was introduced into the diagnostic service by the 
end of 2011. 
Supervisors were appointed on the BM, FISH, QF-PCR and 
amniotic fluid benches to improve on methodologies, TAT and 
to maintain consistency in training. The TAT of amniotic fluid 
cultures was less than 14 days. The demand for the introduction of 
more haematological FISH probes had resulted in the expansion of 
the probe inventory. A plasma cell labelling technique for multiple 
myeloma was introduced for a more accurate result. The need for 
the implementation of cytogenomic microarray was still shown to 
be of great importance. The feasibility study undertaken proved the 
efficacy of this technology through the results obtained. TR attended 
a 1-month training course at the Laboratory of Diagnostic Genomic 
Analysis in Leiden, Netherlands, in 2015.
Conclusion
In summary, the cytogenetics laboratory has evolved into a multi-
faceted, multi-tasking facility since the early days with the addition 
of new tests and an increase in sample volume and staff. The 
laboratory staff have always been involved in the training of various 
colleagues within the genetic services. The majority of the intern 
medical technologists passed the Cytogenetic Board Examination 
with distinction. As a SANAS accredited laboratory, the cytogenetics 
laboratory at GSH delivers a quality diagnostic service with an 
excellent TAT. Despite financial and staffing constraints the staff 
have shown perseverance and have focused on the task at hand. The 
future of cytogenetics at GSH is in line with the trend towards the 
next generation of technologies, which includes the continued use of 
high-definition chromosome analysis. Introduction of cytogenomic 
microarray into the diagnostic laboratory is the next goal for this 
laboratory.
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